Roche open to alliances in hunt for cancer drug combinations

April 1, 2015 10:00 AM

16 0

FRANKFURT, April 1 (Reuters) - Roche, the world's largest cancer drugmaker, is ready to collaborate with rivals to find new combination therapies for multi-pronged treatments, its chief executive said.

Severin Schwan said the company was investing very heavily in a new wave of cancer immunotherapy drugs, where finding combination therapies to attack tumours on different fronts would be "extremely important".

Also read: ZTE shares rise in Hong Kong after clarification of U.S. bill impact

Read more

To category page